Cargando…
ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives
Angiotensin-converting enzyme 2 (ACE2) is related to ACE but turned out to counteract several pathophysiological actions of ACE. ACE2 exerts antihypertensive and cardioprotective effects and reduces lung inflammation. ACE2 is subjected to extensive transcriptional and post-transcriptional modulation...
Autores principales: | Saponaro, Federica, Rutigliano, Grazia, Sestito, Simona, Bandini, Lavinia, Storti, Barbara, Bizzarri, Ranieri, Zucchi, Riccardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556165/ https://www.ncbi.nlm.nih.gov/pubmed/33195436 http://dx.doi.org/10.3389/fmolb.2020.588618 |
Ejemplares similares
-
3-Iodothyronamine and Derivatives: New Allies Against Metabolic Syndrome?
por: Rutigliano, Grazia, et al.
Publicado: (2020) -
ACE2 in the Gut: The Center of the 2019-nCoV Infected Pathology
por: Guo, Yuexin, et al.
Publicado: (2021) -
Combination Therapy Using Inhalable GapmeR and Recombinant ACE2 for COVID-19
por: Verma, Navin Kumar, et al.
Publicado: (2020) -
Corrigendum: ACE2 in the gut: The center of the 2019-nCoV infected pathology
por: Guo, Yuexin, et al.
Publicado: (2022) -
The Tissue Distribution of SARS-CoV-2 in Transgenic Mice With Inducible Ubiquitous Expression of hACE2
por: Dolskiy, Alexander A., et al.
Publicado: (2022)